| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 47,860 | 55,075 | 41,199 | 54,644 | | Cost of Revenue |
-
| (26,641) | 30,079 | 46,061 | | | Gross Profit |
-
| 81,716 | 11,120 | 8,583 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 47,880 | 77,986 | 12,342 | 14,354 | | Non Recurring |
-
|
-
| 14,928 | 56,471 | | Others | 544 | 209 | 209 | 436 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 3,521 | (16,359) | (62,678) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 5,634 | 4,019 | (16,857) | (70,488) | | Interest Expense |
-
| 640 | 180 | (253) | | Income Before Tax | 4,371 | 3,379 | (17,037) | (70,235) | | Income Tax Expense | 856 | 1,282 | (6,473) | (11,897) | | Minority Interest | (1,329) | (2,144) |
-
| 115 | | | | Net Income From Continuing Ops | 4,671 | 941 | (10,564) | (58,338) | | | Non-recurring Events | | Discontinued Operations | (355) | (460) | (1,228) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 843 | 481 | (11,792) | (58,338) | | Preferred Stock And Other Adjustments |
-
| 1,052 | (1,052) |
-
| | | Net Income Applicable To Common Shares | $843 | $1,533 | ($12,844) | ($58,338) |
|
0.51% Nasdaq 
0.11 (2.09%) 
Income Statement
